Browse Category

Earnings Reports News 10 January 2026

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

AnaptysBio filed a motion to dismiss part of GSK’s claim in a Delaware court dispute over royalties from cancer drug Jemperli. The court is expected to hear the motion by early March, with trial set for July. GSK ADRs closed up 0.3% at $50.39 in New York; London shares slipped 0.26% to 1,886 pence. Investors await GSK’s Jan. 13 conference appearance and Feb. 4 results.
Keppel Ltd stock: Feb. 5 results date is set — here’s what traders watch next

Keppel Ltd stock: Feb. 5 results date is set — here’s what traders watch next

Keppel Ltd will release its second-half and full-year 2025 results on Feb. 5, after three Keppel-sponsored REITs report from Jan. 30. Keppel shares closed Friday down 0.7% at S$10.47, trading near a 52-week high. About 2.06 million shares changed hands, with S$10.46 as support and S$10.56 as resistance. All financial releases will be made before market open, the company said.
South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 shares closed up 1.1% at A$3.85, just below their 2026 high, after the miner released its 2026 calendar and set Feb. 12 for half-year results. The company confirmed a March 5 ex-dividend date and flagged a $60 million cost for the Mozal smelter shutdown in Mozambique. The S&P/ASX 200 slipped 0.03% as Rio Tinto fell 6.2%. Glencore shares surged over 10% on takeover talks with Rio Tinto.
Johnson & Johnson stock: TrumpRx drug discounts win tariff waiver as earnings loom

Johnson & Johnson stock: TrumpRx drug discounts win tariff waiver as earnings loom

Johnson & Johnson reached a deal with the Trump administration to cut U.S. drug prices and won exemptions from tariffs on its pharmaceuticals. The company will sell medicines at discounted rates through TrumpRx.gov and announced two new U.S. manufacturing sites. J&J stock closed down 0.7% at $204.39. Terms of the agreement remain confidential.
P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

Procter & Gamble will change Kid’s Crest toothpaste packaging after Texas officials said label artwork encouraged unsafe fluoride use by children. The rollout began Jan. 1 and must last five years. P&G shares closed up 0.24% at $141.87, then slipped 0.17% after hours. Investors await the Jan. 22 earnings call for updates on volumes, pricing, and regulatory scrutiny.
Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify stock dips after broker target cuts — what to watch before SPOT earnings

Spotify shares fell 2.6% to $539.37 Friday after Guggenheim and UBS cut their price targets but kept Buy ratings. The company launched a new podcast studio in Los Angeles and projected podcasts will add $10 billion in value over five years. Investors are watching for signs Spotify can grow revenue without losing subscribers. Fourth-quarter results are due Feb. 10.
1 102 103 104 105 106 204

Stock Market Today

Wilmar (SGX:F34) share price slips as palm oil turns lower; what to watch next week

Wilmar (SGX:F34) share price slips as palm oil turns lower; what to watch next week

8 February 2026
Wilmar International shares fell 0.9% to S$3.44 on Friday as Singapore’s Straits Times Index slipped 0.8%. Malaysian palm oil futures posted their first weekly decline in five weeks ahead of industry events and data releases. The Malaysian Palm Oil Board will report January figures on Feb. 10. Wilmar’s full-year results are due Feb. 26.
Seatrium share price slips: what traders watch before SGX reopens Monday

Seatrium share price slips: what traders watch before SGX reopens Monday

8 February 2026
Seatrium shares closed down 1% at S$2.06 Friday ahead of full-year results due Feb. 26. The company marked a key offshore wind platform milestone with TenneT and GE Vernova this week. Investors are watching for updates on project progress, cash flow, and new orders as markets reopen Monday.
CapitaLand Investment share price jumps into earnings week as 9CI closes at S$3.12

CapitaLand Investment share price jumps into earnings week as 9CI closes at S$3.12

8 February 2026
CapitaLand Investment shares closed up 1.3% at S$3.12 on Friday, outperforming the STI, which fell 0.83%. CapitaLand Integrated Commercial Trust reported a 16.4% rise in second-half distributable income to S$449 million and a 9.4% increase in distribution per unit. Full-year results for CapitaLand Investment are due Feb. 11. Markets are closed for the weekend.
Go toTop